Demographic and clinical characteristics were comparable
between the intervention and control group at
baseline (table 1). Mean HbA1c for the intervention
and control group was 6.49% (SD 0.4%) and 6.82%
(SD 0.5%), respectively. The intervention group demonstrated
a significant reduction in HbA1c (−0.18%
(0.2%); p=0.018) while no reduction was seen in the
control group (+0.03% (0.2%)); p value for difference
between groups was 0.032.